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Strengths and limitations of this study
 ► Identification of the individual factors which may 
influence patients’ behaviours when they are con-
sidering undergoing cytological testing at primary 
healthcare (PHC) office.
 ► Joining the patients’ answers with the characteris-
tics of their physicians.
 ► Study conducted in randomly selected PHC offices 
(minimal sample size reached in both the physician 
and patient groups).
 ► The percentage of women who would be willing 
to receive pap smears at their general practitioner 
office is high, which is valuable information from a 
cost-allocation perspective.
 ► Results are not fully representative of the whole 
Polish population (the survey only being conducted 
in one region).
AbStrACt
background Despite worldwide efforts in encouraging 
routine pap smears for early detection of cervical cancer, 
Poland’s screening rate lags behind the rest of the 
European Union at 20.2%. Family physicians (FPs) in 
Poland rarely perform pap smears, and little is known 
about the experiences and attitudes of Polish patients 
regarding pap smear screening in a primary healthcare 
(PHC) setting.
Methods A cross-sectional questionnaire-based survey 
was performed. Questionnaires were distributed among 
43 FPs and 418 of their patients in one Polish region. 
The data from patients were associated with the doctors’ 
characteristics. Descriptive statistics, the χ2 test and the 
Mann-Whitney U test were used for analysis.
results Nearly two-thirds of patients (66%) declared 
willingness to undergo free pap smear screening by their 
FPs, with the most common reason being time saved. 
Among those objecting to receive pap smears from their 
FPs, immediate specialist care provided by gynaecologists 
in case of adverse results was the main concern. The 
factors that positively influenced the patients’ decision 
to undergo cervical cancer screening in PHC were: (1) 
living in a city with more than 100 000 inhabitants, (2) 
being single, (3) having a female FP or (4) a physician with 
specialty training in family medicine.
Conclusion There is high level of acceptance for pap 
smears performed in PHC offices among patients in 
Poland. They are more likely to comply with the screening 
due to easy access. Establishing a solid physician–patient 
relationship is also crucial in encouraging screening.
IntroduCtIon
The WHO estimates that about 266 000 
women die of cervical cancer annually, 
making this one of the leading causes of 
cancer death in the world. Despite the high 
mortality rate, cervical cancer is a largely 
preventable disease. Human papillomavirus 
(HPV) is one of the most common sexually 
transmitted infections worldwide, and is 
noted as a necessary cause of cervical cancer 
development.1 2 In particular, high risk HPV 
subtypes 16 and 18 are commonly found to 
be present in cervical tumours.3–6
It is estimated that approximately 70% of 
cases of cervical cancer around the globe are 
associated with HPV types 16 and 18.7 Active 
immunisation against these subtypes has 
shown to decrease the prevalence of HPV8 
and the incidence of cervical malignancies.9 
In addition to immunisation, routine Papa-
nicolau testing (pap smear) is an effective 
screening tool that allows for early detec-
tion of cervical cancer. Studies have shown 
that cytological screening decreases the 
incidence10–12 and mortality rate of cervical 
cancer.11–15
According to statistics collected in 2012 
by Institut Catala d’Oncologia HPV Centre, 
over 1800 deaths occur every year as a 
result of cervical cancer in Poland, making 
it the second leading cause of cancer death 
in women. There is a national screening 
programme done by National Health Service 
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Fund’s which relies on sending invitations by post to 
encourage patients to perform regular pap smears. 
Despite that, the pap smear screening rate in Poland is 
a shockingly low 20.2%, as compared with a 70%–80% 
screening rate in other European Union (EU) coun-
tries.16 In an effort to increase screening rates, pap smears 
are generally performed by primary healthcare (PHC) 
physicians in many countries all over the world such as 
Canada, Germany, Spain and Portugal, which greatly 
differs from Poland where pap smears are performed 
almost exclusively by gynaecologists.17 18
In addition, Poland is one of the few countries in the 
EU that does not currently have an HPV vaccination 
programme for target populations.16 In order to develop 
strategies that can efficiently accomplish cervical cancer 
prevention, it is essential to obtain a thorough under-
standing of the determinants contributing to the low 
screening rate in Poland. Implementing pap smears in 
PHC offices may be one of the solutions to increase the 
effectiveness of cervical cancer screening in Poland.
Our study aims to answer the following questions:
1. What is the PHC patient’s experience with pap smear 
testing?
2. What is the level of the PHC patient’s willingness to 
undergo screening at PHC offices?
3. Are there any associations between the professional 
characteristics of PHC physicians and their patients 
which could influence the readiness for cytological 
screening in a PHC setting?
MAterIAl And MethodS
Study design
A cross-sectional questionnaire-based study was conducted 
from January to December 2017 in Malopolska region 
(Krakow and surrounding small towns and villages). The 
data were collected by medical students and physicians, 
who had all received appropriate training and instruc-
tions regarding the study protocol. All patients were 
surveyed after their visit to their family physician (FP), 
while all physicians completed their surveys at the end of 
the consultation session.
Sampling
The sample size was calculated using OpenEpi software. 
The sample size formula n=[(DEFF×Np(1 p)]/[(d2/
Z21−α/2×(N−1)+p×(1 p)] was used to calculate the 
number of patients and physicians needed for this study. 
For the patient sample (population size n=1 000 000 
female inhabitants of Malopolska region aged 18–55, 
anticipated % frequency of patients willing to undergo 
pap smear in a FP office population based on pilot 
study results p=36%, absolute error or precision d=5%, 
design effect (DEFF)=1.0, significance level α=5%, 
Z1−α/2=1.96), the minimum patient sample size (n) 
was estimated to be 354. The minimum physician sample 
size was calculated to be 41 (n=702 primary care prac-
tices registered in Malopolska region, p=87%, d=10%, 
DEFF=1.0, α=5%, Z1−α/2=1.96). As in survey research, 
physicians are recognised as a professional group from 
which it is difficult to obtain high responses, therefore, 
a sample size of 200 physicians was chosen. To avoid bias 
related to practices selection random sampling by means 
of random-number table was used. To draw the sample, 
we used a local register of PHC physicians provided by the 
National Health Service Fund.
Patient and public involvement
The purpose of the study was thoroughly explained to 
all participants. The study was conducted according to 
Guideline for Good Clinical Practice rules. The authors 
enforced the highest ethical standards for this study. The 
authors made sure that high standards were implemented 
in: comprehensive documentation for the study protocol, 
record keeping, training of field workers, and facilities, 
including computers and software. Phone inquiries were 
made to the managers of the selected practices to ask for 
their permission to conduct the study in their practice. 
After receiving written consent from them, one physician 
from each of these practices was asked for their willingness 
to participate in this study. On a set date, the fieldworker 
visited the participating PHC practice, obtained written 
consent from the PHC physician and handed her/him 
the questionnaire. Then, in the waiting-hall, the field-
worker consecutively invited the first 10 eligible patients 
who were visiting the selected PHC for various reasons to 
participate in the study. Women aged 18–55 years, with 
the ability to give informed consent were eligible to take 
part in the study.
In order to link individual participants with their 
responses we assigned each participant a study ID prior 
to collecting data. Each participant’s name along with 
their unique study ID (eg, 001) were entered into a sepa-
rate document. While collecting the data we entered 
each participant’s unique study ID into their data docu-
ment. To protect confidentiality, we used study codes on 
completed questionnaires and kept a separate document 
that linked the study code to subjects’ identifying infor-
mation locked in a separate location with restricted access 
to this document.
For the purpose of the study, two questionnaires were 
designed by the study team: one for patients and one for 
PHC physicians. The initial questionnaires were prepared 
based on information acquired from the review of interna-
tional literature. We did not find similar studies so all the 
questionnaires’ elements were designed by the authors 
after taking into consideration the aims of the research 
project. Both initially prepared questionnaires were then 
validated in a pilot study. There were 127 patients and 33 
doctors in the pilot study who evaluated the face validity. 
The comments of the participants in the pilot study were 
directed at providing clarification of questions or adding 
more open questions. On the basis of both doctors and 
patients comments the final version of the questionnaire 
was developed. We used Cronbach’s alpha to see if the 
multiple-item Likert scale questions were reliable. For 
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Table 1 PHC physicians’ characteristics and their patients’ willingness to undergo pap smear screening at their PHC office
PHC physicians’ characteristics
Patients willing to undergo 
screening at his/her PHC 
office N (%)
Patients not willing to 
undergo screening at his/
her PHC office N (%) P value
Gender
  Female 162 (64.80) 66 (51.16) p=0.010
  Male 88 (35.20) 63 (48.84)
Medical specialty: family medicine   
  Yes 232 (95.47) 103 (88.03) p=0.009
  No 11 (4.53) 14 (11.93)
Population of patients   
  Adults and children 173 (71.19) 87 (74.36) p=0.530
  Adults 70 (28.81) 30 (25.64)
Years of experience in PHC   
  Less than 5 78 (32.10) 31 (26.50) p=0.362
  5–15 years 84 (34.57) 49 (41.88)
  More than 15 81 (33.33) 37 (31.62)
PHC, primary healthcare.
each set of Likert scale questions, we achieved acceptable 
reliability (Cronbach’s alpha >0.6).
After data analysis the posters explaining the results 
and conclusions were displayed in all practices where the 
study was conducted.
Research tool
Finally, the patient questionnaire consisted of 25 ques-
tions, including four multiple-item Likert scale and nine 
semi-open questions (see online supplementary file). The 
rest of the questions were multiple choice questions with 
the possibility to choose one or more predefined answers. 
The first set of questions was related to sociodemographic 
measures and the respondents’ profile (number of preg-
nancies and children, gender of their FP, sexual activity). 
This part also involved questions regarding the patient’s 
family medical history, specifically concerning female 
reproductive organ cancers. The next section integrated 
questions concerning the individuals’ knowledge about 
cervical cancer and their attitude towards pap smears 
(how often do they undergo this examination, where, 
reasons for not doing this regularly). The last part of the 
questionnaire included a patient behavioural assessment 
which included questions regarding whether or not the 
patients wish to have the possibility of undergoing cervical 
cancer screening in their PHC office and why or why not.
The physicians’ questionnaire data were gathered 
concerning the physicians’ sex, age, location of the prac-
tice, number of patients seen at the practice per week, 
medical specialty and number of years in practice.
Statistical analysis
Statistical analysis was conducted using Statistica V.13.1 
software. To present the results we used descriptive statis-
tics. To investigate the associations between the attitude 
towards pap smears in a PHC setting and patients’ and 
their doctors’ characteristics, the χ2 test was used for qual-
itative variables and the Mann-Whitney U test was used 
for quantitative variables. Multivariate logistic regression 
analysis was used to measure for final associations between 
patients’ characteristics and the willingness for screening 
in PHC adjusted for covariates.
There were few missing data in the questionnaires in 
different variables, although none of this was exceeding 
the 10% of all responses and therefore this was omitted in 




We reached 200 physicians in their PHC centres. Finally, 
43 physicians agreed to participate in the study (response 
rate 21.5%). Of all doctors participating—24 were women 
(56%). The mean age of physicians was 39.5 years (±SD 
9.25). The physicians’ characteristics together with the 
dimension of their patients’ features, depending on their 
willingness to undergo a pap smear in their practice are 
shown in table 1.
Of 430 eligible patients, 418 consented to participate 
(response rate 97.2%). The mean age of the patients was 
39.1 years (±SD 10.68). The patient’s age did not have an 
influence on attitude towards cervical screening. Table 2 
presents patients’ characteristics.
Patients’ pap smear experience and values
The majority of patients surveyed (94%) indicated that 
they have had at least one pap smear performed at some 
time in the past. Less than a half (46%) declared their last 
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Table 2 Patients’ characteristics and their willingness to 












N (%) P value
Place of living
  Village 69 (28.05) 62 (48.06) p<0.001
  Town <25 000 11 (4.47) 6 (4.65)
  Town 25 000–
100 000
28 (11.38) 18 (13.95)
  City >100 000 138 (56.10) 43 (33.33)
Education
  Less than high 
school
7 (27.78) 6 (4.51) p=0.256
  High school 
equivalent
103 (40.87) 63 (47.37)
  University 
education
142 (56.35) 64 (48.12)
Marital status
  Single 72 (30.13) 21 (16.67) p=0.030
  Married 151 (63.18) 91 (72.22)
  Divorced 13 (5.44) 12 (9.52)
  Widowed 3 (1.26) 2 (1.59)
Sexual activity
  Yes 206 (80.78) 105 (79.55) p=0.771





  Yes 65 (26.10) 27 (20.76) p=0.250




  Private practice 114 (44.88) 55 (41.35) p=0.846
  Private and 
public practice
11 (4.33) 8 (6.02)
  Public practice 99 (38.98) 54 (40.60)
  None 16 (6.30) 30 (22.56)
Vaccination against 
HPV
  Yes 12 (4.78) 7 (5.38) p=0.797
  No 239 (95.22) 123 (94.62)
Pap smear ever 
done
  Yes 235 (92.16) 126 (96.18) p=0.1
  No 20 (7.84) 5 (3.82)
HPV, human papillomavirus; PHC, primary healthcare.
Figure 1 Patients’reasons for undergoing free pap smear by 
their PHC physician. PHC, primary healthcare.
pap smear was within the last 12 months, 34% indicated 
their last pap smear was 1–3 years ago and for 20% it was 
over 3 years ago. About 49% of study participants reported 
getting a pap smear regularly every 3 years, 32% of getting 
it once per year, 9% every 5 years and 10% less than every 
5 years. Half of the studied patients paid privately for a 
pap smear. Only 8% of females received and responded 
to the National Health Service Fund’s invitation to get 
pap smear testing financed by the government. Only 5% 
of respondents were vaccinated against HPV.
The most frequent reason (48%) for not getting pap 
smears given by patients was not having any worrying 
symptoms, and therefore, they did not feel the need to 
get a pap smear. The other answers justifying non-ad-
herence were as follows: lack of time (39%), young age 
(32%), embarrassment (16%), fear of bad results (12%).
Two-thirds of study participants declared a willingness 
to undergo free pap smear screening by their PHC physi-
cians. In this group, most patients (64%) agreed that by 
visiting a PHC office frequently, there will be no need to 
sacrifice additional time for pap smears at a specialist’s 
office.
Figure 1 presents patients’ motivations behind wanting 
to have their pap smear testing performed in their PHC 
office.
Among those objecting to receiving pap smears from 
PHC physicians (34%), specialist care provided by gynae-
cologists in case of adverse results was the main concern 
(83% of unwilling patients).
Figure 2 presents patients’ reasons against undergoing 
free pap smear by their PHC physician.
Factors affecting willingness to undergo pap smear in a PhC 
office
Detailed information about the associations between 
patients’ characteristics and the willingness to undergo 
screening at a PHC office is shown in table 2. Patients’ 
features related with significantly higher will to undergo 
pap smear testing in a PHC setting were living in big cities 
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Figure 2 Patients’reasons against undergoing free pap 
smear by their primary healthcare physician.
Table 3 Logistic regression model: willingness to undergo 
screening in primary healthcare as associated with patients’ 
characteristics (OR estimates and 95% CIs of or estimates, 











Town <25 000 1.32 0.44 3.95
Town 25 000–100 000 1.46 0.70 3.07





High school equivalent 0.55 0.15 2.04





Married 0.51 0.27 0.95
Divorced 0.33 0.12 0.93
Widowed 0.76 0.10 5.64
Sexual activity
  No Yes 0.59 0.30 1.18
Family history of female reproductive cancer
  No Yes 0.75 0.43 1.30




Private practice 0.91 0.41 2.02
Private and public 
practice
0.76 0.35 1.66
Public practice 0.60 0.18 2.01
Vaccination against HPV




  No Yes 1.49 0.47 4.53
Age
    0.86 0.25 3.01
HPV, human papillomavirus.
and being single. Further analysis of the data hasn’t shown 
a correlation between patients’ age and the willingness to 
undergo pap smear in a PHC office (p=0.129). The results 
of the multivariate analysis are shown in table 3. Patients 
living in cities with population greater than 100 000 citi-
zens were more willing to undergo pap smear in PHC 
than village inhabitants (OR=2.76; p<0.001). Regarding 
marital status, both married and divorced patients were 
less likely to agree for testing by PHC physicians than 
single patients (OR=0.51; p=0.035 and OR=0.33; p=0.034, 
respectively).
Table 1 presents associations between PHC physicians’ 
characteristics and their patients’ willingness to undergo 
pap smear screening at their PHC office. Our study 
revealed that the gender and specialty training in family 
medicine of the PHC doctor are also factors that have a 
positive influence on the patients’ attitude in this matter. 
In fact, patients of female doctors were significantly 
more willing to have pap smears in their PHC office than 
patients whose doctor was male (p=0.010).
Physicians’ age and workload featured by number of 
patient visits per week were not determining factors.
dISCuSSIon
Summary and interpretation of results
Our findings provide a clearer picture of what factors 
influence cervical cancer screening rates. The study 
revealed that a majority of surveyed patients were willing 
to undergo pap smear screening at their PHC office. The 
reasoning behind this was that they do not need to seek a 
gynaecologist, will have shorter waiting times, their FP is 
more easily accessible and saving time for screening.
However, those who were unwilling were mostly 
concerned with possible lack of access to direct gynae-
cological consultation in case of abnormal or uncertain 
results.
This intersection of both patient and physician charac-
teristics gives some insight into how the patient–doctor 
relationship is crucial in maintaining adherence to 
screening regimes. We found that female FP were more 
likely to have patients well-disposed to undergoing pap 
smears in the PHC setting. A likely reason for this is a 
greater level of comfort for the patient to have gynaeco-
logical procedures performed by a physician of the same 
sex.
The only physician characteristic to significantly impact 
patient openness to screening in the PHC setting was 
a specialisation in family medicine (according to the 
current law in Poland, the PHC doctors can be specialists 
in family medicine, paediatrics or internal medicine).
This could be accounted for by the unique character-
istics that set FPs apart from other specialties—longer, 
deeper patient relationships, a greater focus on patient 
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education, greater comfort with screening and perhaps 
the greater emphasis placed on women’s health in family 
medicine practice than in internal medicine or another 
specialisation. It is important to note that neither the 
age of the doctor nor the size of the patient load were 
correlated with patient disposition toward screening; and 
similarly, among patients neither age nor education were 
found to be significant.
Of the patient characteristics studied, it was found that 
marital status (being single) and area of residence (living 
in a city) where significantly correlated with willingness 
to undergo pap smears in the PHC setting. Considering 
that age is not a confounding factor, the significance of 
marital status could be explained as an increased aware-
ness in single women of sexually transmitted diseases and 
so a tendency to view screening as important and routine; 
if single women are more likely to see the utility of a pap 
smear, they would also be more likely to have it done in a 
PHC setting where it is more easily accessible.
The fact that living in a city is significant on the other 
hand, speaks quite clearly to cultural differences between 
urban and rural centres in the attitude toward screening, 
personal modesty, what the traditional roles of doctors 
should be and different levels of exposure to medical 
practice.
Strengths and limitations of the study
Gathered data allowed for an examination of the indi-
vidual factors which may influence patients’ behaviours 
when they are considering undergoing cytological testing 
at their PHC office. The strength of the study was also the 
possibility of joining the patients’ answers with the char-
acteristics of their physicians.
Additionally, the study was conducted in randomly 
selected PHC offices, with the minimal sample size 
reached in both: physician and patient groups, and 
included participants from urban, suburban and rural 
communities. The study was performed anonymously so 
we may suspect that respondents answered the questions 
truthfully.
Nevertheless, the study also had some limitations. The 
results are not fully representative of the whole Polish 
population due to the survey only being conducted in 
one, however, large region. So, there is no reason to 
believe that in other regions the situation might be better. 
Moreover, only patients who visited their PHC physician 
were questioned. We may suspect that there is a number 
of patients who are not visiting their PHC office and that 
some of them receive pap smears at their gynaecologists’ 
offices while the rest are not regularly seeking medical 
care at all.
Even though the estimation of the percentage of women 
who regularly perform the pap smears was not the primary 
focus of our study, we noted that received results showed 
a higher percentage of women who declare receiving 
regular pap smears compared with national statistics. This 
may be due to the fact that not all pap smears done by 
private gynaecologists are recorded in the general Polish 
data base, and that we need to approach the national data 
with caution.
On the other hand, it is also possible that the study 
participants provided responses which are more socially 
desirable, even when answering anonymously, thereby 
inflating the number of women receiving screening. This 
might be due to the fact that numerous public campaigns 
are trying to encourage women to perform regular pap 
smears. Moreover, we received answers from women who 
might be more concerned about their health as they visit 
their FPs, in comparison to other potential patients who 
don’t.
Nonetheless, the percentage of women who would 
be willing to receive pap smears at their general prac-
titioner (GP) office is high, which is valuable informa-
tion from a cost-allocation perspective. Also, the studied 
group are patients whose attitudes towards pap smears 
may be potentially influenced by their physicians, there-
fore the population is congruent with the purpose of the 
study.
Comparison with other studies
Our findings were in line with a study performed by Favre 
et al in 2018 in France, a nation where similarly GPs often 
do not perform pap smears.19 In their study, the participa-
tion rate in cervical cancer screening was slightly higher 
when a PHC physician performed smears and when the 
physician was female. The study assessing patient and 
physician factors influencing participation in cervical 
cancer screening in Norway revealed that higher non-ad-
herence rates were associated with having a male PHC 
physician, which is in line with our findings.20 An inter-
esting finding of a recent study in Serbia was that women 
who regularly received pap smears showed more neutral 
when choosing a gynaecologist, unlike the less adherent 
groups that preferred a female physician.21 This suggests 
that with cervical cancer screening becoming more wide-
spread, the barrier to have the test performed by a male 
PHC physician may lessen. This study also revealed that 
women irregularly or never received a pap smear mainly 
because of lack of knowledge about pap smears, difficult 
access to healthcare facilities, lack of time, discomfort 
and anxiety of pap smear results.21 A study performed in 
Switzerland revealed that the main reasons for non-par-
ticipation in cervical cancer screening were practical 
barriers, such as lack of time and the cost of screening.22 
The two aforementioned studies and our study support 
the idea that convenience and accessibility may be 
major obstacles in achieving a greater degree of cervical 
cancer screening in the population. In the Norwegian 
study, higher non-adherence rates were associated with 
a greater distance to the screening site which is indi-
rectly consistent with our results with regard to living in 
an urban setting.20 We found being single was associated 
with a higher likelihood to agree to pap smear screening 
in the PHC office, though Leinonen et al and a study in 
Lithuania by Petkeviciene et al, found being single was 
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associated with non-adherence, suggesting that willing-
ness to undergo screening and later adherence are not 
necessarily correlated.20 23
Implications for practice and screening policy
There is a need to educate women regarding the impor-
tance of cervical cancer screening. The role of FPs as 
health advocates, as well as a community resource for 
health education, is essential to reduce the morbidity and 
mortality from cervical cancer. Our results demonstrate 
that too many women were neglecting their screening 
because they had no symptoms. Clearly it is vital that 
doctors inform patients of the silent nature of cervical 
cancer, and that the purpose of the screening test is not 
to confirm a diagnosis, but rather precisely to catch the 
cancer when it is still asymptomatic. Statements such as 
these show that patients do not understand the funda-
mental purpose of the screening test; adherence will not 
increase if patients are not clear as to the aim of the test. 
In addition, fears concerning the safety of the test and 
the need for ‘specialised’ interventions should adverse 
events occur also reveal a need for a greater level of 
patient education. Formal intensive screening for cervical 
cancer should be launched and supported across Poland. 
These services if conducted at PHC offices could poten-
tially avoid long wait times and additional scheduling 
complexity at gynaecological offices.
In order to decrease the mortality of patients with posi-
tive cytological testing, there should be a fast track system 
to gynaecological care in place to expedite medical or 
surgical treatment. We believe that results from this inves-
tigation will streamline the organisation of a pilot study 
with the goal of studying and introducing more effective 
cervical cancer screening in the Małopolska region and 
therefore promote improvements to current Polish PHC.
ConCluSIon
It is crucial to improve the accessibility to cervical cancer 
screening for patients in Poland. Strategies must be 
tailored to the needs of the patients; effective approaches 
should be multifaceted. This requires effective inter-
ventions that will concentrate not only on increasing 
awareness of the importance of prevention and the need 
for regular pap smears, but also by providing conve-
nient means by which to undergo the test. Taking into 
the account the high mortality of the cervical cancer in 
Poland we believe that our study shows possible area of 
improvement.
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